Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

391
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
391
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

242
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
242
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

90
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
90
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

188
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
188
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

397
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
397
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

299
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
299

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-reported unmet healthcare needs among people with diabetic kidney disease in primary care in Peninsular Malaysia: a sequential mixed-methods study.

BMJ open·2026
Same author

Validation of Multi-Target Stool DNA Methylation Test for Colorectal Cancer Detection: A Preliminary Analysis.

Biomedicines·2026
Same author

Clinical and Biochemical Factors Associated with Delayed Renal Response in Proliferative Lupus Nephritis: A 20-Year Single-Center Multiethnic Cohort Study.

Biomedicines·2026
Same author

The cascade of care for latent tuberculosis infection in Malaysia: a cohort analysis.

BMC infectious diseases·2026
Same author

Changes in suicide rates in Malaysia during the COVID-19 pandemic: An interrupted time series analysis.

Journal of affective disorders·2026
Same author

Undiagnosed Diabetes and Prediabetes in Yemen: A Growing Public Health Crisis in the Shadow of Conflict.

Medicina (Kaunas, Lithuania)·2026

Related Experiment Video

Updated: Dec 6, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.6K

The chronic kidney disease perception scale (CKDPS): development and construct validation.

Haryati Anuar1,2, Shamsul Azhar Shah3, Abdul Halim Abdul Gafor3

  • 1Department of Community Health, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaakob Latiff, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia. mrssyawal@gmail.com.

BMC Nephrology
|October 8, 2020
PubMed
Summary
This summary is machine-generated.

A new scale, the Chronic Kidney Disease Perception Scale (CKDPS), was developed to assess how diabetic patients perceive chronic kidney disease (CKD) prevention. This validated tool measures perceptions based on Social Psychology and the Health Belief Model (HBM).

Keywords:
Chronic kidney disease perception scaleConstruct validityFactor analysis

More Related Videos

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.3K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.7K

Related Experiment Videos

Last Updated: Dec 6, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.6K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.3K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.7K

Area of Science:

  • Nephrology
  • Psychology
  • Public Health

Background:

  • Chronic kidney disease (CKD) is a global health issue often asymptomatic until advanced stages.
  • Early detection and intervention are critical for managing CKD progression.
  • Diabetic patients are at increased risk for CKD, necessitating tailored assessment tools.

Purpose of the Study:

  • To develop and validate the Chronic Kidney Disease Perception Scale (CKDPS).
  • To assess diabetic patients' perceptions of CKD prevention.
  • To base the scale on Social Psychology principles and the Health Belief Model (HBM).

Main Methods:

  • A cross-sectional study involving 300 diabetic patients.
  • Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) were used for validation.
  • Assessed construct validity, internal consistency, and model-fit indices.

Main Results:

  • The EFA identified nine domains: illness identity, timeline motivation, medical practice, cooperation (Social Psychology), and perceived benefit, barriers, susceptibility, severity, and cue to action (HBM).
  • Four low-factor-loading items were removed.
  • CFA confirmed good model fit for both Social Psychology and HBM constructs, with acceptable fit indices (GFI, CFI, RMSEA, NC).

Conclusions:

  • The CKDPS is a valid and reliable 61-item instrument for measuring diabetic patients' perceptions of CKD prevention.
  • The scale is divided into nine domains under Social Psychology and HBM.
  • The CKDPS can be utilized in larger studies for assessing CKD prevention perceptions in diabetic populations.